Antifibrotic Therapies Market to Exceed $28.7 Billion by 2033 at 12.6% CAGR
Antifibrotic Therapies Market to Exceed $28.7 Billion by 2033 at 12.6% CAGR The global Antifibrotic Therapies market is experiencing strong expansion due to the increasing prevalence of chronic fibrotic diseases. In 2023, the market was valued at approximately $8.9 billion, and it is projected to reach $28.7 billion by 2033, growing at a compound annual growth rate (CAGR) of 12.6%. Over...
0 التعليقات 0 المشاركات 20 مشاهدة 0 معاينة